Page last updated: 2024-10-17

n(1)-methylnicotinamide and Fibrosis

n(1)-methylnicotinamide has been researched along with Fibrosis in 1 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, W1
Rong, G1
Gu, J1
Fan, C1
Guo, T1
Jiang, T1
Deng, W1
Xie, J1
Su, Z1
Yu, Q1
Mai, J1
Zheng, R1
Chen, X1
Tang, X1
Zhang, J1

Other Studies

1 other study available for n(1)-methylnicotinamide and Fibrosis

ArticleYear
Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022, Volume: 36, Issue:3

    Topics: Animals; Cells, Cultured; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Niacinamide; Nicotinamid

2022